RECRUITING

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to collect data to evaluate utility of the using photon-counting CT in a clinical setting.

Official Title

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Quick Facts

Study Start:2023-09-07
Study Completion:2025-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05838482

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Who are 18 years of age or older
  2. * Able to sign and date the informed consent form
  3. * Who have in the past 120 days or will in the future 30 days undergo a clinically-indicated CT exam of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior scheduled exam
  1. * Who are pregnant or lactating;
  2. * Who were previously enrolled in this study;
  3. * For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents
  4. * For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel;
  5. * Who need urgent or emergent care;
  6. * Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; OR
  7. * Who are unwilling to have GEHC personnel present for the CT exam.

Contacts and Locations

Study Contact

Melissa Challman
CONTACT
+1-858-221-3007
melissa.challman@gehealthcare.com

Principal Investigator

Brian Thomsen
STUDY_DIRECTOR
GE Healthcare

Study Locations (Sites)

Stanford University
Palo Alto, California, 94304
United States

Collaborators and Investigators

Sponsor: GE Healthcare

  • Brian Thomsen, STUDY_DIRECTOR, GE Healthcare

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-07
Study Completion Date2025-05

Study Record Updates

Study Start Date2023-09-07
Study Completion Date2025-05

Terms related to this study

Additional Relevant MeSH Terms

  • CT Photon-Counting